These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10393009)

  • 1. Multiple sclerosis trials.
    Kappos L
    Lancet; 1999 Jun; 353(9171):2242-3. PubMed ID: 10393009
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis.
    Ford H; Nicholas R
    Clin Evid; 2005 Dec; (14):1637-51. PubMed ID: 16620466
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin and multiple sclerosis.
    Achiron A; Miron S
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):247-54. PubMed ID: 16391400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are clinical trials of therapeutic agents for MS long enough?
    Rudge P
    Lancet; 1999 Mar; 353(9158):1033-4. PubMed ID: 10199348
    [No Abstract]   [Full Text] [Related]  

  • 6. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.
    McDonald WI; Miller DH; Thompson AJ
    Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple sclerosis.
    Boggild M; Ford H
    Clin Evid; 2003 Jun; (9):1459-73. PubMed ID: 15366193
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiple sclerosis--recent advances in pathogenesis and treatment].
    Itoyama Y; Fujihara K; Nakashima I; Misu T; Fujimori T; Sato S
    No To Shinkei; 2002 Jan; 54(1):5-21. PubMed ID: 11868352
    [No Abstract]   [Full Text] [Related]  

  • 9. How should we proceed with disease-modifying treatments for multiple sclerosis?
    Andersson PB; Waubant E; Goodkin DE
    Lancet; 1997 Mar; 349(9052):586-7. PubMed ID: 9057726
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-specific immunosuppressants in the treatment of multiple sclerosis.
    Confavreux C; Vukusic S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natalizumab (Tysabri) returns.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):76. PubMed ID: 16977289
    [No Abstract]   [Full Text] [Related]  

  • 12. New treatments and azathioprine in multiple sclerosis.
    Kolar OJ
    Lancet; 1997 Oct; 350(9083):1033. PubMed ID: 9329539
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple sclerosis in children].
    Neuteboom RF; Catsman-Berrevoets CE; Hintzen RQ
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1464-8. PubMed ID: 17633977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fragile benefit of BENEFIT.
    Coles A
    Lancet Neurol; 2007 Sep; 6(9):753-4. PubMed ID: 17706555
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon beta in multiple sclerosis: how much BENEFIT?
    Pittock SJ
    Lancet; 2007 Aug; 370(9585):363-4. PubMed ID: 17678997
    [No Abstract]   [Full Text] [Related]  

  • 16. Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG].
    Rieckmann P; Toyka KV
    Eur Neurol; 1999; 42(3):121-7. PubMed ID: 10529535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ["The largest snapshot of multiple sclerosis". Interferons compared].
    MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866307
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon beta-1a and beta-1b for treatment of multiple sclerosis.
    Kappos L
    Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424020
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alpha interferon in the treatment of multiple sclerosis. Update and experience in Cuba].
    Cabrera-Gómez JA; López-Saura P
    Rev Neurol; 1999 May 1-15; 28(9):849-58. PubMed ID: 10390746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
    Gout O
    Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.